Video

Novartis Contract Manufacturing Capacity Update February 2024: Cell & Gene

Source: Novartis Contract Manufacturing

This presentation from the February 2024 OPCU event provides an overview of the Cell and Gene manufacturing services provided by Novartis Contract Manufacturing and how the in-house capabilities within the Novartis network can support clients' needs in end-to-end production. Gain insight to their new viral vector facility and available capacity in this session.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: